BRIEF published on 12/17/2025 at 14:43, 4 days 19 hours ago First Berlin Equity Research met à jour sa recommandation sur Cardiol Therapeutics, passant à « Acheter » avec un objectif de cours abaissé. Recommandation D'achat Ajustement Du Prix Cible Thérapeutique Cardiaque Étude ARCHER De Phase II Myocardite
BRIEF published on 12/17/2025 at 14:43, 4 days 19 hours ago First Berlin Equity Research Updates Cardiol Therapeutics to "Buy" with a Lowered Target Price Buy Recommendation Target Price Adjustment Cardiol Therapeutics Phase II ARCHER Study Myocarditis
PRESS RELEASE published on 12/17/2025 at 14:38, 4 days 19 hours ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., lowering price target to USD 7.80 based on positive Phase II ARCHER data on CardiolRx for acute myocarditis First Berlin Equity Research Buy Recommendation Acute Myocarditis Cardiol Therapeutics Inc. Phase II ARCHER Data
BRIEF published on 10/23/2025 at 12:56, 1 month 29 days ago Cardiol Therapeutics Secures Funding with USD 11.4 Million Private Placement Private Placement Clinical Trials Financial Outlook Cardiol Therapeutics Heart-Failure Therapy
BRIEF published on 10/23/2025 at 12:56, 1 month 29 days ago Cardiol Therapeutics obtient un financement avec un placement privé de 11,4 millions de dollars Placement Privé Essais Cliniques Cardiol Therapeutics Perspectives Financières Traitement De L'insuffisance Cardiaque
PRESS RELEASE published on 10/23/2025 at 12:51, 1 month 29 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Cardiol Therapeutics Inc with a BUY rating and USD 8.50 price target. The private placement secures funds for pivotal trials and new product development Private Placement Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating USD 8.50 Price Target
BRIEF published on 08/12/2025 at 13:36, 4 months 9 days ago Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
BRIEF published on 08/12/2025 at 13:36, 4 months 9 days ago Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis
PRESS RELEASE published on 08/12/2025 at 13:31, 4 months 9 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc after positive phase II trial results for CardiolRx in acute myocarditis Cardiol Therapeutics Inc First Berlin Equity Research Phase II Trial CardiolRx Acute Myocarditis
BRIEF published on 04/23/2025 at 15:29, 7 months 28 days ago Cardiol Therapeutics Advances in Pivotal Phase III Study FDA Approval Cardiol Therapeutics Phase III Study Recurrent Pericarditis CardiolRxT
Published on 12/22/2025 at 08:05, 1 hour 46 minutes ago Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
Published on 12/20/2025 at 00:30, 2 days 9 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 11 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 15 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 19 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/22/2025 at 09:30, 21 minutes ago Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability
Published on 12/22/2025 at 09:22, 29 minutes ago Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth
Published on 12/22/2025 at 09:22, 29 minutes ago Heirs Energies conclut un accord de financement de 750 millions USD avec Afreximbank pour stimuler sa croissance à long terme
Published on 12/22/2025 at 09:00, 50 minutes ago Original-Research: Cantourage Group SE (von NuWays AG): BUY
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 11 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Réduction du capital par voie d’annulation d’actions propres
